Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio Key International (BKYI) Other Non-Current Liabilities (2016)

Bio Key International (BKYI) has disclosed Other Non-Current Liabilities for 4 consecutive years, with $1206.0 as the latest value for Q3 2016.

  • Quarterly Other Non-Current Liabilities fell 98.71% to $1206.0 in Q3 2016 from the year-ago period, while the trailing twelve-month figure was $1206.0 through Sep 2016, down 98.71% year-over-year, with the annual reading at $104284.0 for FY2015, 141.25% up from the prior year.
  • Other Non-Current Liabilities hit $1206.0 in Q3 2016 for Bio Key International, down from $153790.0 in the prior quarter.
  • In the past five years, Other Non-Current Liabilities ranged from a high of $405428.0 in Q1 2014 to a low of $1206.0 in Q3 2016.
  • Historically, Other Non-Current Liabilities has averaged $135663.5 across 4 years, with a median of $93198.0 in 2015.
  • Biggest YoY gain for Other Non-Current Liabilities was 430.79% in 2016; the steepest drop was 98.71% in 2016.
  • Year by year, Other Non-Current Liabilities stood at $243077.0 in 2013, then tumbled by 82.22% to $43227.0 in 2014, then soared by 141.25% to $104284.0 in 2015, then crashed by 98.84% to $1206.0 in 2016.
  • Business Quant data shows Other Non-Current Liabilities for BKYI at $1206.0 in Q3 2016, $153790.0 in Q2 2016, and $104284.0 in Q4 2015.